CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,327 | -43.0% | 356,994 | 0.0% | 0.00% | – |
| Q2 2023 | $428,393 | +381.3% | 356,994 | +369.3% | 0.00% | – |
| Q1 2023 | $89,005 | +48.1% | 76,073 | 0.0% | 0.00% | – |
| Q4 2022 | $60,098 | -35.4% | 76,073 | 0.0% | 0.00% | – |
| Q3 2022 | $93,000 | +32.9% | 76,073 | 0.0% | 0.00% | – |
| Q2 2022 | $70,000 | -88.9% | 76,073 | -78.4% | 0.00% | – |
| Q1 2022 | $632,000 | +44.3% | 352,850 | +24.3% | 0.00% | – |
| Q4 2021 | $438,000 | -24.1% | 283,787 | 0.0% | 0.00% | – |
| Q3 2021 | $577,000 | -41.6% | 283,787 | 0.0% | 0.00% | – |
| Q2 2021 | $988,000 | +1183.1% | 283,787 | +559.5% | 0.00% | – |
| Q1 2021 | $77,000 | – | 43,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |